CLINICAL STUDIES
Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging
Sherif Iskander, MDa and
Ami E. Iskandrian, MD, FACCa
a Division of Cardiology, Department of Medicine, MCP–Hahnemann School of Medicine, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA
Manuscript received December 24, 1997;
revised manuscript received March 16, 1998,
accepted March 20, 1998.
Address for correspondence: Ami E. Iskandrian, Cardiovascular Research Center, Allegheny University of the Health Sciences, 230 North Broad Street, Mail Stop 471, Philadelphia, Pennsylvania 19102
iskandrian{at}auhs.edu
Objectives. This review summarizes the results of single-photon emission computed tomographic (SPECT) technetium-99m (Tc-99m) tracer imaging in patients with stable symptoms, patients with acute coronary syndromes, patients undergoing major noncardiac surgery and patients with chest pain in the emergency department.
Background. Previous studies have examined the prognostic value of stress thallium imaging in several subsets of patients with ischemic heart disease. At present, >50% of myocardial perfusion studies are performed with technetium-labeled tracers in the United States. Furthermore, there is a shift from diagnostic to the prognostic utility of stress testing. There are important differences between technetium-labeled tracers and thallium-201. It is therefore important to review the prognostic value of technetium-labeled tracers.
Methods. We analyzed published reports in English on risk assessment using Tc-99m perfusion tracers.
Results. The largest experience is in patients with stable symptoms, comprising >12,000 patients in 14 studies. In these patients, normal stress SPECT sestamibi images were associated with an average annual hard event rate of 0.6% (death or nonfatal myocardial infarction [MI]). In contrast, patients with abnormal images had a 12-fold higher event rate (7.4% annually). Both fixed and reversible defects are prognostically important, and quantitative analysis shows increased risk in relation to the severity of the abnormality. These results are similar to those obtained with thallium-201.
Conclusions. Patients with stable chest pain syndromes and normal stress SPECT sestamibi images have a very low risk of death or nonfatal MI. It is highly unlikely that coronary revascularization can improve survival in such patients. Patients with abnormal images have an intermediate to high risk for future cardiac events, depending on the degree of the abnormality. Further prospective studies comparing aggressive medical therapy with coronary revascularization in these patients are warranted.
|
Abbreviations and Acronyms
| | CABG | = coronary artery bypass graft surgery | | CAD | = coronary artery disease | | LV | = left ventricular | | LVEF | = left ventricular ejection fraction | | MI | = myocardial infarction | | PTCA | = percutaneous transluminal coronary angioplasty | | SPECT | = single-photon emission computed tomography (tomographic) | | Tc-99m | = technetium-99m | | Tl-201 | = thallium-201 |
|
This article has been cited by other articles:
|
|
|
|
 
B. A. Herzog, L. Husmann, I. Valenta, O. Gaemperli, P. T. Siegrist, F. M. Tay, N. Burkhard, C. A. Wyss, and P. A. Kaufmann
Long-Term Prognostic Value of (13)N-Ammonia Myocardial Perfusion Positron Emission Tomography Added Value of Coronary Flow Reserve.
J. Am. Coll. Cardiol.,
July 7, 2009;
54(2):
150 - 156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Kaufmann, P. G. Camici, and S. R. Underwood
CHAPTER 7 Nuclear Cardiology
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Baggish and C. A. Boucher
Radiopharmaceutical Agents for Myocardial Perfusion Imaging
Circulation,
October 14, 2008;
118(16):
1668 - 1674.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Gaemperli, T. Schepis, I. Valenta, P. Koepfli, L. Husmann, H. Scheffel, S. Leschka, F. R. Eberli, T. F. Luscher, H. Alkadhi, et al.
Functionally Relevant Coronary Artery Disease: Comparison of 64-Section CT Angiography with Myocardial Perfusion SPECT
Radiology,
August 1, 2008;
248(2):
414 - 423.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sato, M. Hiroe, M. Tamura, H. Ohigashi, T. Nozato, H. Hikita, A. Takahashi, K. Aonuma, and M. Isobe
Quantitative Measures of Coronary Stenosis Severity by 64-Slice CT Angiography and Relation to Physiologic Significance of Perfusion in Nonobese Patients: Comparison with Stress Myocardial Perfusion Imaging
J. Nucl. Med.,
April 1, 2008;
49(4):
564 - 572.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Schaeffer, T. D. Brennan, J. A. Hughes, W. B. Gibler, and M. C. Gerson
Resting Radionuclide Myocardial Perfusion Imaging in a Chest Pain Center Including an Overnight Delayed Image Acquisition Protocol
J. Nucl. Med. Technol.,
December 1, 2007;
35(4):
242 - 245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Wu, F. M. Bengel, and S. S. Gambhir
Cardiovascular Molecular Imaging
Radiology,
August 1, 2007;
244(2):
337 - 355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Yoshinaga, B. J.W. Chow, K. Williams, L. Chen, R. A. deKemp, L. Garrard, A. Lok-Tin Szeto, M. Aung, R. A. Davies, T. D. Ruddy, et al.
What is the Prognostic Value of Myocardial Perfusion Imaging Using Rubidium-82 Positron Emission Tomography?
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
1029 - 1039.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Miller, R. F. Redberg, and F. J.T. Wackers
Screening Asymptomatic Diabetic Patients for Coronary Artery Disease: Why Not?
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
761 - 764.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Bax, R. O. Bonow, D. Tschope, S. E. Inzucchi, E. Barrett, and on behalf of the Global Dialogue Group for the Eva
The Potential of Myocardial Perfusion Scintigraphy for Risk Stratification of Asymptomatic Patients With Type 2 Diabetes
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
754 - 760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. V. Anand, E. Lim, A. Lahiri, and J. J. Bax
The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects
Eur. Heart J.,
April 2, 2006;
27(8):
905 - 912.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Reyes and S. R. Underwood
Myocardial perfusion scintigraphy: an important step between clinical assessment and coronary angiography in patients with stable chest pain
Eur. Heart J.,
January 1, 2006;
27(1):
3 - 4.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J Bax, R. O Bonow, D. Tschoepe, S. E Inzucchi, and E. J Barrett
Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease: implications for expanded use of myocardial perfusion imaging
The British Journal of Diabetes & Vascular Disease,
September 1, 2005;
5(5):
283 - 288.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Hacker, T. Jakobs, F. Matthiesen, C. Vollmar, K. Nikolaou, C. Becker, A. Knez, T. Pfluger, M. Reiser, K. Hahn, et al.
Comparison of Spiral Multidetector CT Angiography and Myocardial Perfusion Imaging in the Noninvasive Detection of Functionally Relevant Coronary Artery Lesions: First Clinical Experiences
J. Nucl. Med.,
August 1, 2005;
46(8):
1294 - 1300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Liao, W. T. Smith IV, R. H. Tuttle, L. K. Shaw, R. E. Coleman, and S. Borges-Neto
Prediction of Death and Nonfatal Myocardial Infarction in High-Risk Patients: A Comparison Between the Duke Treadmill Score, Peak Exercise Radionuclide Angiography, and SPECT Perfusion Imaging
J. Nucl. Med.,
January 1, 2005;
46(1):
5 - 11.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Marshall, P. Powers-Risius, B. W. Reutter, J. P. O'Neil, M. La Belle, R. H. Huesman, and H. F. VanBrocklin
Kinetic Analysis of 18F-Fluorodihydrorotenone as a Deposited Myocardial Flow Tracer: Comparison to 201Tl
J. Nucl. Med.,
November 1, 2004;
45(11):
1950 - 1959.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S L Rahman and A D Kelion
Nuclear cardiology in the UK: do we apply evidence based medicine?
Heart,
August 1, 2004;
90(suppl_5):
v37 - v40.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Tschoepe and W. Burchert
Non-invasive imaging for coronary artery disease in diabetes
The British Journal of Diabetes & Vascular Disease,
July 1, 2004;
4(4):
245 - 250.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. A. Beller and D. D. Watson
Risk stratification using stress myocardial perfusion imaging: don't neglect the value of clinical variables
J. Am. Coll. Cardiol.,
January 21, 2004;
43(2):
209 - 212.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. S. Thomas, M. I. Miyamoto, A. P. Morello III, H. Majmundar, J. J. Thomas, C. H. Sampson, R. Hachamovitch, and L. J. Shaw
Technetium99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting: The Nuclear Utility in the Community (NUC) Study
J. Am. Coll. Cardiol.,
January 21, 2004;
43(2):
213 - 223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Abidov, J. J. Bax, S. W. Hayes, R. Hachamovitch, I. Cohen, J. Gerlach, X. Kang, J. D. Friedman, G. Germano, and D. S. Berman
Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT
J. Am. Coll. Cardiol.,
November 19, 2003;
42(10):
1818 - 1825.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N K Sabharwal and A Lahiri
Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease
Heart,
November 1, 2003;
89(11):
1291 - 1297.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Elhendy, D. W. Mahoney, B. K. Khandheria, K. Burger, and P. A. Pellikka
Prognostic significance of impairment of heart rate response to exercise: Impact of left ventricular function and myocardial ischemia
J. Am. Coll. Cardiol.,
September 3, 2003;
42(5):
823 - 830.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Shaw, R. Hendel, S. Borges-Neto, M. S. Lauer, N. Alazraki, J. Burnette, E. Krawczynska, M. Cerqueira, and J. Maddahi
Prognostic Value of Normal Exercise and Adenosine 99mTc-Tetrofosmin SPECT Imaging: Results from the Multicenter Registry of 4,728 Patients
J. Nucl. Med.,
February 1, 2003;
44(2):
134 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F.L. Schinkel, A. Elhendy, R. T. van Domburg, J. J. Bax, J. R.T.C. Roelandt, and D. Poldermans
Prognostic Value of Dobutamine-Atropine Stress 99mTc-Tetrofosmin Myocardial Perfusion SPECT in Patients with Known or Suspected Coronary Artery Disease
J. Nucl. Med.,
June 1, 2002;
43(6):
767 - 772.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. J. Chamuleau, R. A. Tio, C. C. de Cock, E. D. de Muinck, N. H. J. Pijls, B. L. F. van Eck-Smit, K. T. Koch, M. Meuwissen, M. G. W. Dijkgraaf, A. de Jong, et al.
Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease
J. Am. Coll. Cardiol.,
March 6, 2002;
39(5):
852 - 858.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Wayhs, A. Zelinger, and P. Raggi
High coronary artery calcium scores pose an extremely elevated risk for hard events
J. Am. Coll. Cardiol.,
January 16, 2002;
39(2):
225 - 230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Giri, L. J. Shaw, D. R. Murthy, M. I. Travin, D. D. Miller, R. Hachamovitch, S. Borges-Neto, D. S. Berman, D. D. Waters, and G. V. Heller
Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease
Circulation,
January 1, 2002;
105(1):
32 - 40.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B S McGlone and K K Balan
The use of nuclear medicine techniques in the emergency department
Emerg. Med. J.,
November 1, 2001;
18(6):
424 - 429.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Shaw, A. E. Iskandrian, R. Hachamovitch, G. Germano, H. C. Lewin, T. M. Bateman, and D. S. Berman
Evidence-Based Risk Assessment in Noninvasive Imaging
J. Nucl. Med.,
September 1, 2001;
42(9):
1424 - 1436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.C. Allman and L.E.J. Thomson
Prognostic value of myocardial perfusion imaging in patients with known or suspected coronary artery disease
Eur. Heart J. Suppl.,
September 1, 2001;
3(suppl_F):
F5 - F7.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L.J. Shaw, D.S. Berman, and D.D. Miller
Cost-effectiveness of myocardial perfusion imaging in the evaluation of patients with known or suspected coronary artery disease
Eur. Heart J. Suppl.,
September 1, 2001;
3(suppl_F):
F15 - F18.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. A. Beller and B. L. Zaret
Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease
Circulation,
March 28, 2000;
101(12):
1465 - 1478.
[Full Text]
[PDF]
|
|
|
|
